Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer Research|January 13, 2026
NRF1 Induces ApoEhigh Cancer-Associated Fibroblasts to Promote Stemness of Renal Cell CarcinomaYing Zhang, Zhouting Tuo, Yuan Lin, et al.
Materials Today. Bio|August 12, 2025
Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translationDilinaer Wusiman, Yu Wang, Minghao Wang, et al.
Oncology Research|February 16, 2024
Pan-cancer analysis of RNA 5-methylcytosine reader (ALYREF)Xing Ye, Zhouting Tuo, Kai Chen, et al.
Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu|July 11, 2024
Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysisDechao Feng, Yuhan Xiao, Jie Wang, et al.
Discover Oncology|May 12, 2024
Prognostic significance and immune landscape of a cell cycle progression-related risk model in bladder cancerZhouting Tuo, Yuan Lin, Ying Zhang, et al.
Aging and Disease|November 29, 2023
Targeting Prolyl 4-Hydroxylase Subunit Beta (P4HB) in Cancer: New Roads to TravelDechao Feng, Jie Wang, Dengxiong Li, et al.
Aging and Disease|April 12, 2024
Chronobiology of the Tumor Microenvironment: Implications for Therapeutic Strategies and Circadian-Based InterventionsDengxiong Li, Qingxin Yu, Ruicheng Wu, et al.
International Journal of Surgery (London, England)|January 19, 2024
SKA3 targeted therapies in cancer precision surgery: bridging bench discoveries to clinical applications - review articleDechao Feng, Jie Wang, Yuhan Xiao, et al.
Research (Washington, D.C.)|April 3, 2026
Peripheral Nerve-Cancer Interactions in the Tumor Microenvironment: A Three-Dimensional Framework Integrating Mechanisms, Modulators, and Therapeutic StrategiesFanglin Shao, Jie Wang, Aiqing Li, et al.
Metabolism: Clinical and Experimental|August 30, 2025
Modulating metabolism to improve the therapeutic outcomes of CAR cell therapies: From bench to bedsideDengxiong Li, Jie Wang, Ruicheng Wu, et al.
Pageof 5